CCR2基因敲除对延迟性肩袖修复小鼠模型肌腱生物力学特性的影响
研究在52只12周龄雄性C57BL/6J小鼠中比较CCR2基因敲除(CCR2KO)与野生型(WT)在延迟性肩袖修复模型中的肌腱愈合效果。CCR2KO组失败载荷和刚度均显著高于WT组,巨噬细胞百分比显著降低,步态分析无显著差异。作者认为CCR2可能通过减少巨噬细胞浸润或抑制炎症介质通路改善肌腱生物力学特性。
要点
- CCR2KO组失败载荷2.50±0.42 N显著高于WT组1.64±0.41 N(p=0.030)。
- CCR2KO组刚度3.00±0.95 N/mm显著高于WT组1.43±0.66 N/mm(p=0.008)。
- CCR2KO组巨噬细胞百分比5.8%显著低于WT组8.1%(p=0.035)。
核心结论
- 在延迟性肩袖修复模型中,CCR2基因敲除可能通过减少巨噬细胞浸润和/或抑制炎症介质通路来改善肌腱生物力学特性。
- 作者认为CCR2可能是降低肩袖修复失败率的新型治疗靶点。
研究设计与样本
- 研究将52只12周龄雄性小鼠分配至野生型(WT)组和CCR2基因敲除(CCR2KO)组。
- 所有小鼠在初次手术中行单侧冈上肌腱(SST)离断,2周后行延迟修复。
- 主要结局指标为生物力学测试,次要指标包括组织学、基因表达分析、流式细胞术和步态分析。
主要发现
- 平均失败载荷WT组为1.64±0.41 N,CCR2KO组为2.50±0.42 N(p=0.030)。
- 平均刚度WT组为1.43±0.66 N/mm,CCR2KO组为3.00±0.95 N/mm(p=0.008)。
- 转录谱分析显示CCR2KO组与WT组比较有7个差异表达基因(DEGs)(p<0.05),I型和II型干扰素通路评分存在显著差异(p<0.01)。
- 流式细胞术显示巨噬细胞百分比WT组为8.1%,CCR2KO组为5.8%(p=0.035)。
- 步态分析显示两组间无显著差异。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The high incidence of incomplete or failed healing after rotator cuff repair (RCR) has led to an increased focus on the biologic factors that affect tendon-to-bone healing. Inflammation plays a critical role in the initial tendon-healing response. C-C chemokine receptor type 2 (CCR2) is a chemokine receptor linked to the recruitment of monocytes in early inflammatory stages and is associated with an increase in pro-inflammatory macrophages. The purpose of this study was to evaluate the role of CCR2 in tendon healing following RCR in C57BL/6J wildtype (WT) and CCR2-/- knockout (CCR2KO) mice in a delayed RCR model. METHODS: Fifty-two 12-week-old, male mice were allocated to 2 groups (WT and CCR2KO). All mice underwent unilateral supraspinatus tendon (SST) detachment at the initial surgical procedure, followed by a delayed repair 2 weeks later. The primary outcome measure was biomechanical testing. Secondary measures included histology, gene expression analysis, flow cytometry, and gait analysis. RESULTS: The mean load-to-failure was 1.64 ± 0.41 N in the WT group and 2.50 ± 0.42 N in the CCR2KO group (p = 0.030). The mean stiffness was 1.43 ± 0.66 N/mm in the WT group and 3.00 ± 0.95 N/mm in the CCR2KO group (p = 0.008). Transcriptional profiling demonstrated 7 differentially expressed genes (DEGs) when comparing the CCR2KO and WT groups (p < 0.05) and significant differences in Type-I and Type-II interferon pathway scores (p < 0.01). Flow cytometry demonstrated significant differences between groups for the percentage of macrophages present (8.1% for the WT group compared with 5.8% for the CCR2KO group; p = 0.035). Gait analysis demonstrated no significant differences between groups. CONCLUSIONS: CCR2KO may potentially improve tendon biomechanical properties by decreasing macrophage infiltration and/or by suppressing inflammatory mediator pathways in the setting of delayed RCR. CLINICAL RELEVANCE: CCR2 may be a promising target for novel therapeutics that aim to decrease failure rates following RCR.
引用
- Eliasberg CD, Carballo CB, Piacentini A, et al. Effect of CCR2 Knockout on Tendon Biomechanical Properties in a Mouse Model of Delayed Rotator Cuff Repair. J Bone Joint Surg Am. 2023. PMID: 36947666. doi:10.2106/JBJS.22.01160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。